Giuseppe Ciaramella, President & CSO at Beam Therapeutics Inc. (BEAM), sold 104,958 shares at $39.07 ($3.9M) on 2023-01-03, disclosed to the SEC on 2023-01-05.
Open-market sale of $3.9M BEAM by President & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.14 | 37,525 | $1.4M | 35.5% |
| 2 | $37.14 | 37,525 | $1.4M | 35.5% |
| 3 | $37.99 | 13,704 | $521K | 13.3% |
| 4 | $37.99 | 13,704 | $521K | 13.3% |
| 5 | $39.07 | 1,900 | $74K | 1.9% |
| 6 | $39.94 | 600 |
| $24K |
| 0.6% |
| Total | $37.41 avg | 104,958 | $3.9M | 100% |
| Filing → |
| BEAM | SELL | 2025-04-03 | $273K | — | Filing → |
| BEAM | SELL | 2024-11-08 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-10-16 | $2.7M | — | Filing → |